Kocar, M. Et Al. 2014. p95-HER2 and trastuzumab resistance in metastatic breast cancer; is immunohistochemistry appropriate?. JOURNAL OF BUON , vol.19 , 245-249.

Kocar, M., Bozkurtlar, E., Telli, F., Yumuk, F., Kaya, H., Kocar, H., ... Turhal, N. S.(2014). p95-HER2 and trastuzumab resistance in metastatic breast cancer; is immunohistochemistry appropriate?. JOURNAL OF BUON , vol.19, 245-249.

Kocar, Muharrem Et Al. "p95-HER2 and trastuzumab resistance in metastatic breast cancer; is immunohistochemistry appropriate?," JOURNAL OF BUON , vol.19, 245-249, 2014

Kocar, Muharrem Et Al. "p95-HER2 and trastuzumab resistance in metastatic breast cancer; is immunohistochemistry appropriate?." JOURNAL OF BUON , vol.19, pp.245-249, 2014

Kocar, M. Et Al. (2014) . "p95-HER2 and trastuzumab resistance in metastatic breast cancer; is immunohistochemistry appropriate?." JOURNAL OF BUON , vol.19, pp.245-249.

@article{article, author={Muharrem Kocar Et Al. }, title={p95-HER2 and trastuzumab resistance in metastatic breast cancer; is immunohistochemistry appropriate?}, journal={JOURNAL OF BUON}, year=2014, pages={245-249} }